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Toxic waste sites threaten the environment 
and human health in countries around the 
world. In developing countries these sites—
and their risks to human health—have not 
been optimally assessed (Yáñez et al. 2002). 
Quantification of the burden of disease from 
toxic waste sites can assist public health plan-
ning and remediation efforts by complement-
ing traditional waste site investigations and by 
framing these toxic exposures in the context of 
other exposures. Burden of disease estimates 
are typically expressed in  disability-adjusted 
life years (DALYs). The DALY metric 
accounts for both the morbidity and mortal-
ity that result from a disease, injury, or health 
state (Prüss-Üstün et al. 2003).
Previous calculations of the burden of dis-
ease from toxic exposures have not included 
estimates from toxic waste sites because of 
an absence of data on exposures and health 
impacts. In 2004, Fewtrell et al. (2004) esti-
mated that lead causes nearly 1% of the global 
burden of disease. Then in 2011, Prüss-Üstün 
et al. (2011) calculated that exposure to a vari-
ety of chemicals, including lead, secondhand 
smoke, and asbestos, accounts for 5.7% of 
total global DALYs and 8.3% of total global 
deaths. However, because of insufficient data, 
neither of these studies included estimates for 
disease and death attributable to exposures 
from toxic waste sites.
We aimed to develop a DALY-based 
estimate of the burden of disease and death 
attributable to toxic waste sites in India, 
Indonesia, and the Philippines. To our 
knowledge, no systematic evaluation of 
toxic waste sites in low- and middle-income 
countries (LMICs) had previously been per-
formed. The paucity of data has precluded 
calculation of the burden of disease result-
ing from exposures at these sites. Through 
this effort we hope to ultimately calculate the 
contribution of toxic waste sites to the global 
burden of disease.
Methods
Site identification. In this study, we utilized 
data collected through Blacksmith Institute’s 
Toxic Sites Identification Program (TSIP), 
an effort to identify and screen contaminated 
sites in LMICs (Blacksmith Institute 2013). 
The TSIP, which is implemented jointly with 
the United Nations Industrial Development 
Organization, identifies point-source pollution 
from industrial sites that present a public 
health risk. A particular focus is placed on 
abandoned (legacy) sites, such as former tan-
neries, as well as small-scale artisanal sources, 
such as lead battery recycling and artisanal gold 
mining. Although other sources of contamina-
tion, such as large-scale mining, may also be 
included and screened, the majority of sites 
come from these two categories (i.e., legacy 
sites and artisanal sources). The TSIP excludes 
nonpoint sources, such as ambient urban air 
pollution, and non- chemical contamination, 
such as sewage-contaminated water. Ericson 
et al. (2012) described the types of sites identi-
fied in the TSIP.
The Blacksmith Institute developed 
an evaluation instrument, the Initial Site 
Screening (ISS), for rapid data collection and 
assessment of these sites (Blacksmith Institute 
2013). The ISS is a modified and simplified 
version of the U.S. Environmental Protection 
Agency’s (EPA) Hazard Ranking System, 
used to prioritize and rank toxic waste sites 
in the U.S. EPA’s Superfund program (U.S. 
EPA 2012b). The ISS includes information 
on the concentration of the key toxic chemi-
cal, the primary environmental medium of 
the exposure pathway, and the size of the 
population at risk.
To undertake the TSIP, the Blacksmith 
Institute contracted and trained approxi-
mately 150 site investigators. These investi-
gators identified and visited sites, collected 
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Background: Prior calculations of the burden of disease from toxic exposures have not included 
estimates of the burden from toxic waste sites due to the absence of exposure data.
oBjective: We developed a disability-adjusted life year (DALY)-based estimate of the disease 
burden attributable to toxic waste sites. We focused on three low- and middle-income countries 
(LMICs): India, Indonesia, and the Philippines.
Methods: Sites were identified through the Blacksmith Institute’s Toxic Sites Identification 
Program, a global effort to identify waste sites in LMICs. At least one of eight toxic chemicals was 
sampled in environmental media at each site, and the population at risk estimated. By combining 
estimates of disease incidence from these exposures with population data, we calculated the DALYs 
attributable to exposures at each site.
results: We estimated that in 2010, 8,629,750 persons were at risk of exposure to industrial pol-
lutants at 373 toxic waste sites in the three countries, and that these exposures resulted in 828,722 
DALYs, with a range of 814,934–1,557,121 DALYs, depending on the weighting factor used. This 
disease burden is comparable to estimated burdens for outdoor air pollution (1,448,612 DALYs) 
and malaria (725,000 DALYs) in these countries. Lead and hexavalent chromium collectively 
accounted for 99.2% of the total DALYs for the chemicals evaluated.
conclusions: Toxic waste sites are responsible for a significant burden of disease in LMICs. 
Although some factors, such as unidentified and unscreened sites, may cause our estimate to be an 
under estimate of the actual burden of disease, other factors, such as extrapolation of environmental 
sampling to the entire exposed population, may result in an over estimate of the burden of disease 
attributable to these sites. Toxic waste sites are a major, and heretofore underrecognized, global 
health problem.
key words: Asia, burden of disease, chemical exposure, disability-adjusted life year, toxic waste sites.
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environmental samples, took photographs and 
GPS coordinates, interviewed stakeholders, 
and categorized the potential contaminated 
environmental media. After being educated on 
the project and assured that participation in 
the interview process was voluntary, the stake-
holders agreed to participate; written informed 
consent was not obtained. The investigators 
determined the dominant pollutant for each 
site based in part on prior testing or historical 
use of a site, then took samples to measure 
levels of the pollutant, typically in only one 
environmental medium. For sites where only 
total chromium was reported, the speciation 
coefficient of 0.6 was used to estimate hexa-
valent chromium (Avudainayagam et al. 2003; 
Kumar and Riyazuddin 2010). Between 2009 
and 2012, investigators completed 1,510 such 
screenings in 49 countries. Since the majority 
of screenings occurred in 2010, we used 2010 
as our baseline year for analysis. We have previ-
ously described the ISS protocol and TSIP in 
detail (Ericson et al. 2012).
Population at risk of exposure. As part of 
the ISS, investigators estimated the popula-
tion at risk of exposure for each site, indicat-
ing the number of persons regularly coming 
into contact with the contaminant in the rel-
evant environmental medium. For example, 
if water contamination is documented, then 
the population at risk includes those indi-
viduals who use the water daily for drinking, 
food preparation, and other domestic pur-
poses. Investigators used a range of approaches 
to obtain this information, including visual 
methods, satellite photographs, community 
census data, government interviews, and per-
sonal knowledge. The age distribution at sites 
was not recorded as part of the ISS. Therefore, 
we applied age distribution estimates from the 
U.S. Census Bureau (2012) for each coun-
try to the population around each site within 
that country. We divided each site’s estimated 
population into 17 age groups based on these 
distributions (e.g., 0–4, 5–9, 10–14 years).
The World Health Organization (WHO) 
DALY calculator for cardio vascular disease 
resulting from adult lead exposure uses 5 age 
groups (i.e., 15–29, 30–44, 45–59, 60–69, 
70–79 years). In this study, we condensed the 
17 age groups into the appropriate 5 groups to 
enable our calculations.
Calculating risk per person. We divided 
human health effects into cancer and noncan-
cer effects. For carcinogens, we used the U.S. 
EPA’s Regional Screening Level Calculator 
for Chemical Contaminants to calculate long-
term cancer risk per unit toxicant (i.e., can-
cer probability per milligram per kilogram 
soil for agents found in soil or microgram per 
liter water for waterborne agents) (U.S. EPA 
2012c). For noncancer health effects, reference 
doses (RfDs) and concentrations (RfCs) from 
the U.S. EPA’s Integrated Risk Information 
System (IRIS) database were applied to the 
exposure pathways and contamination levels 
at each site (U.S. EPA 2012a). The modeling 
assumed a linear dose response and used the 
health outcome associated with the RfD or 
RfC (e.g., liver toxicity, renal toxicity). A list-
ing of the cancer and noncancer risks per unit 
of contaminant, with the exception of lead, 
is presented in Table 1. Given the availabil-
ity of lead-specific modeling tools and dose–
response relationships, we calculated disease 
incidence and DALYs from lead separately.
Calculating incidence of disease. For each 
chemical, we considered up to three envi-
ronmental media (soil, water, air) and cor-
responding routes of exposure (ingestion, 
dermal, and/or inhalation). To calculate dis-
ease incidence for all chemicals except lead, 
we multiplied the risk per person by the level 
of the contaminant in the relevant environ-
mental medium. Because linear slope factors 
were utilized to calculate incidence, very high 
concentrations of contaminants resulted in 
correspondingly high estimates of disease inci-
dence. To accommodate this limitation of the 
model, we arbitrarily capped incidence for all 
diseases at 5%.
For lead, we calculated the incidence of 
mild mental retardation and anemia in chil-
dren and cardio vascular disease in adults 
resulting from lead-induced increases in blood 
pressure. We calculated the predicted mean 
blood lead levels (BLLs) that would result 
from lead exposures at each site by enter-
ing the soil and drinking-water lead levels 
measured at each site into the U.S. EPA’s 
Integrated Exposure, Uptake and Biokinetic 
(IEUBK) model for lead and Adult Lead 
Methodology (ALM) (Caravanos et al. 2012; 
U.S. EPA 1994; White et al. 1998). We 
calibrated default soil ingestion levels in the 
IEUBK model upward from 200 mg/day to 
400 mg/day. This approach follows similar 
analyses done in Native American populations 
(400 mg/day), as well as in indigenous popu-
lations in Micronesia (500 mg/day), and is 
above the “upper bound” level (200 mg/day) 
used by the U.S. EPA (Harris and Harper 
2004; Sun and Meinhold 1997; U.S. EPA 
2011). Then we calculated the incidence of 
mild mental retardation and cardio vascular 
outcomes that would result from such BLLs, 
using spreadsheets developed by the WHO 
(2013). We also assumed that 20% of chil-
dren with BLLs > 70 µg/dL develop anemia 
(Fewtrell et al. 2003).
Calculating years lived with disabil-
ity (YLDs) and years of life lost (YLLs). The 
DALY metric is the sum of two components: 
YLD, which represents disease-related mor-
bidity, and YLL, which represents the prema-
ture mortality from the disease. We calculated 
YLD and YLL for exposure to each contam-
inant through each relevant environmental 
medium. YLD is the product of the estimated 
years lived with a given disability multiplied 
by its specific disability weight (DW). The 
DW is a value from zero to one, depending 
on the severity of each disease, with zero rep-
resenting ideal health and one representing 
death. For example, periodontal disease has a 
DW of 0.001, whereas a first-time stroke has a 
DW of 0.920 (WHO 2008).
For each chemical, we assigned the rel-
evant type of cancer, noncancer health effect, 
and corresponding DW (Table 2) (U.S. 
EPA 2012a; WHO 2008). If the chemical’s 
health effect did not align with a disease in 
the WHO DW database, then we selected 
the most appropriate disease and DW on 
the basis of the target organ, duration of dis-
ease, and severity of disease. In the case of 
noncarcino genic effects, the total number of 
years of life remaining at onset was multiplied 
by the appropriate DW to determine YLD 
(Prüss-Üstün et al. 2003). We chose to apply 
the exposure for the remainder of an individ-
ual’s life expectancy given that most LMICs 
do not have a systemic program to identify 
and remediate these sites. For carcinogens, we 
applied a DW and duration to each cancer 
stage: diagnosis (cancer-specific DW; 3 years); 
metastasis (DW 0.75; 1 year); and terminal 
(DW 0.81; 1 year) (WHO 2008). YLLs were 
calculated only for carcinogens. We used can-
cer incidence and survival data to calculate 
the resulting number of deaths (Ferlay et al. 
2010; Sankaranarayanan et al. 2010). All can-
cers were assumed to last 5 years, before either 
going into remission or resulting in death.
Table 1. Per capita cancer and noncancer human health risks by chemical and media for chemicals 
other than lead.
Chemical (media assessed)
Cancer risk Noncancer risk
Per µg/m3 
in air
Per mg/kg 
in soil
Per µg/L 
in water
Per µg/m3 
in air
Per mg/kg 
in soil
Per µg/L 
in water
Aldrin (W) NA NA 5.35 × 10–4 NA NA 2.22 × 10–6
Asbestos (A) 2.30 × 10–1a NA NA NA NA NA
Cadmium (A,S,W) 1.80 × 10–3 NA NA 5.00 × 10–5 2.67 × 10–8 1.33 × 10–7
Chromium VI (A,S,W) 8.40 × 10–2 9.71 × 10–8b 2.09 × 10–5 NA NA NA
DDT (W) NA NA 1.07 × 10–5 NA NA 1.33 × 10–7
Lindane (S,W) NA 5.08 × 10–6 3.45 × 10–5 NA 8.85 × 10–8 2.22 × 10–7
Mercury, inorganic (A,S,W) NA NA NA 5.68 × 10–8 8.85 × 10–8 2.22 × 10–7
Abbreviations: A, air; DDT, dichlorodiphenyltrichloroethane; NA, not assessed; S, soil; W, water.
aFibers/cubic centimeter. bInhaled airborne dust.
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For lead, we utilized the environmentally 
attributable fraction approach in determining 
the contribution of lead exposure to the bur-
den of cardio vascular disease (ischemic heart 
disease, cerebrovascular disease, hypertensive 
disease, and other cardiac disease) (Fewtrell 
et al. 2003). The WHO has calculated the frac-
tion of cardio vascular disease attributable to 
lead exposure based on BLL. By entering the 
predicted BLL and total cardio vascular disease 
DALYs for each country into a WHO spread-
sheet, we calculated the DALYs attributable to 
cardio vascular disease from lead exposure at 
toxic waste sites in each of the three countries. 
In addition, for children with BLLs > 10 µg/dL 
who did not have mental retardation, we 
applied the DW for developmental disability 
from protein–energy malnutrition (0.024) as 
a proxy DW for lifelong disability from IQ 
loss in the absence of mental retardation. Prior 
research suggests that the loss of IQ points may 
impact cardio vascular and all-cause mortality, 
resulting in increased morbidity and mortality 
(Batty et al. 2010; Lager et al. 2009).
We then applied weighting factors to 
the resulting YLD and YLL for each chemi-
cal, including a discount rate to account for 
inherent inaccuracies when predicting future 
events, and age weights to reflect the relative 
societal value of different age groups (Mathers 
et al. 2006). The notation DALYs(r,K) signi-
fies the discount rate (r) and age weight (K) 
used. Our primary results are expressed as 
DALYs(3,1), which include a 3% discount rate 
and the full age weight. We also calculated 
DALYs(3,0) with the 3% discount rate only, 
and DALYs(0,0) without any weighting to pro-
vide a range of estimates (Mathers et al. 2006).
For example, the drinking water at one 
site in India had an aldrin level of 0.063 
ppb. The oral RfD for aldrin for liver toxic-
ity is 3.0 × 10–5 mg/kg/day, which converts 
to a risk of 8.57 × 10–10 per microgram per 
liter of drinking water (U.S. EPA 2012a, 
2012c). The DW for advanced hepatic disease 
is 0.104. Assuming the 4,000 persons poten-
tially exposed consume 2 L of drinking water 
each day, we calculated 1.62 DALYs(3,0), 1.64 
DALYs(3,1), and 2.02 DALYs(0,0) resulting from 
exposure to aldrin in drinking water at this site.
Sensitivity analysis. In addition to calculat-
ing DALYs with varying rates and weights, 
we also altered inputs into our model to con-
duct a sensitivity analysis. We varied the total 
population at risk by 25%, changed the disease 
incidence cap from the default value of 5% to 
2.5% or 7.5%, and removed the additional 
DW for lead-induced IQ (intelligence quo-
tient) losses that did not result in mild mental 
retardation. For a remediation scenario, we also 
assumed that remediation had reduced all pol-
lutants to concentrations below international 
standards (Blacksmith Institute 2011). By sub-
tracting the resulting DALYs from our primary 
estimate, we quantified the potential impact of 
remediating these sites.
We also estimated that an additional 
5,000 unscreened sites exist in these countries, 
and that these sites present similar conditions 
as the screened sites. The TSIP prioritized 
screenings in part by the scale of the problem, 
measured in population at risk. Thus, these 
5,000 sites are unlikely to have comparably 
large populations. We therefore assumed that 
the population at risk for each of these addi-
tional sites was the median of the population 
at risk of screened sites, which is lower than 
the mean population for screened sites. By 
contrast, the DALY per person estimates for 
the 5,000 unscreened sites are unlikely to be 
lower than those identified at the screened 
sites. Sites were not prioritized for screening 
based on the level of the contaminant in the 
pathway. Therefore, we applied the average 
DALY per person for the screened sites to the 
population at the unscreened sites.
Results
Sites evaluated. Blacksmith Institute–trained 
investigators screened 498 sites in India, 
Indonesia, and the Philippines, with an 
estimated population at risk of exposure of 
approximately 12 million. Of the 23 sepa-
rate chemicals documented at these sites, 
8 occurred at more than one site and had 
established dose–response relationships cor-
relating exposure with specific outcomes. We 
included in the analysis only the 373 sites 
containing 1 of these 8 chemicals. Figure 1 
displays the geographical distribution of the 
Table 2. Cancer and noncancer health effects and DWs of chemicals found at waste sites.
Chemical
Cancer site 
(classification)a
Cancer-specific 
DWb
Health effect  
(noncancer)
DW 
(noncancer)
Aldrin (W) Liver (probable) 0.20 Liver toxicity 0.104c
Asbestos (A) Lung (confirmed) 0.15 NA NA
Cadmium (A) Lung (probable) 0.15 NA NA
Cadmium (W,S) NA NA Renal toxicity 0.091d
Chromium VI (A,W,S) Lung (confirmed) 0.15 NA NA
DDT (W) Liver (probable) 0.20 Liver toxicity 0.104c
Lead (A,W,S) NA NA Mild mental retardation 0.361
Decrement in IQ 0.024e
Cardiovascular disease NAf
Anemia 0.024
Lindane (W,S) Liver (possible) 0.20 Liver toxicity 0.104c
Mercury, inorganic (W,S) NA NA Renal toxicity 0.091d
Abbreviations: A, air; DDT, dichlorodiphenyltrichloroethane; DW, disability weight; NA, not assessed; S, soil; W, water.
aHuman carcinogenicity classification (U.S. EPA 2012a). bCancer-specific DW was applied for a duration of 3 years, 
then a DW of 0.75 was applied for 1 year (metastasis), followed by a DW of 0.81 for 1 year (terminal stage). cAdvanced 
hepatic disease. dAcute glomerulonephritis. eDevelopmental disability associated with protein–energy malnutrition. 
fDALYs calculated with the environmental attributable fraction approach.
Figure 1. Locations of 373 toxic waste sites in India, Indonesia, and the Philippines in 2010.
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sites in India (n = 221), Indonesia (n = 73), 
and the Philippines (n = 79). The estimated 
population at risk of exposure at these 373 
sites was 8,629,750 (mean, 23,136, median, 
7,000), which is 0.61% of the total popula-
tion of the three countries. Of the exposed 
population, 3,449,592 were < 18 years of age 
and 2,184,220 were women of childbearing 
age (15–49 years of age). We estimated that an 
additional 5,000 unscreened sites exist in the 
three countries, with a population of 7,000 
persons per site. This additional population 
equals 35,000,000, resulting in a total popu-
lation of 43,629,750 for the screened and 
unscreened sites.
YLD and YLL at screened sites. We esti-
mated 588,112 person-years lived with disease 
and 240,610 person-years lost as a result of 
chemical exposures in 2010 at the 373 toxic 
waste sites (Table 3). According to our esti-
mates, lead was the largest contributor of the 
eight chemicals to YLD (523,630 YLD, 89% 
of total YLD), and hexavalent chromium 
was the largest contributor to YLL (235,483 
YLL, 97.9% of total YLL). In Table 3, inhala-
tion of soil and dust is incorporated into the 
soil results.
Premature deaths and DALYs at screened 
and unscreened sites.We estimated that 
828,722 DALYs(3,1) resulted from chemi-
cal exposures at the 373 sites in 2010. By 
applying the value of 0.10 DALYs(3,1) per 
person from the screened sites to the popula-
tion at the unscreened sites, we estimated that 
3,500,000 DALYs(3,1) resulted from exposure 
at the unscreened sites. The total estimated 
DALYs(3,1) for the screened and unscreened 
sites was 4,328,722. We also calculated that 
66,747 persons would die prematurely from 
cancer, specifically liver and lung cancer, from 
exposures at these sites.
Sensitivity analysis. Removal of age 
weights yielded 814,934 DALYs(3,0), 
whereas removal of age weights and the dis-
count rate yielded 1,557,121 DALYs(0,0) 
(Table 4). If the actual exposed population 
around these sites is 25% less or 25% greater 
than our estimate, the resulting DALYs(3,1) 
would be 621,541 and 1,035,902, respec-
tively. If the additional DW for lead-induced 
IQ loss not resulting in mental retardation 
is removed, our overall estimate would be 
483,201 DALYs(3,1). In addition, if dis-
ease incidence is capped at 2.5% or 7.5%, 
the resulting DALYs(3,1) would be 730,627 
and 922,479, respectively. The remediation 
scenario yielded 30,317 DALYs(3,1), in con-
trast with our primary estimate of 828,722 
DALYs(3,1). Thus, our estimates suggest that 
798,405 DALYs(3,1) could be eliminated 
by remediation of these sites to achieve 
international standards.
Discussion
We estimated that 8,629,750 persons were 
at risk of exposure to one of eight industrial 
pollutants at 373 toxic waste sites in three 
countries in 2010, resulting in 828,722 
DALYs(3,1). This estimate represents a burden 
of disease equal to 0.22% of the total esti-
mated DALYs(3,1) from all causes in India, 
Indonesia, and the Philippines (WHO 
2008). Alteration of the discount rate and 
age weight leads to a range of estimates, from 
814,934 DALYs(3,0) to 828,722 DALYs(3,1) 
to 1,557,121 DALYs(0,0). Lead and hexava-
lent chromium account for 99.2% of the 
total DALYs estimated for the 8 waste site 
chemical exposures evaluated. The additional 
DW for lead-induced IQ loss not resulting 
in mental retardation accounts for 483,201 
DALYs(3,1), which represents approximately 
58% of total DALYs(3,1). Inclusion of an esti-
mated number of unscreened sites increased 
the estimated population at risk of exposure 
to 43,629,750, and the total DALYs(3,1) to 
4,328,722. As part of a larger project attempt-
ing to calculate the burden of disease of toxic 
waste sites in LMICs, the present analysis 
indicates that the burden of disease associated 
with these sites is substantial and comparable 
to well-described diseases and environmental 
risk factors. For example, the WHO (2009) 
estimated that outdoor air pollution causes 
1,448,612 DALYs(3,1) and malaria causes 
725,000 DALYs(3,1) in these three countries. 
Overall, the present analysis begins to address 
the paucity of knowledge regarding health 
effects from toxic waste sites in LMICs and 
helps frame this issue in the context of other 
public health problems.
Given the limited scope of this project 
and the understanding that the screened sites 
represent only a portion of the total exist-
ing sites, we estimated that 5,000 unscreened 
sites exist in these three countries. The U.S. 
EPA (2004) estimates that there are approx-
imately 294,000 contaminated sites in the 
United States alone that require some form 
of remediation. India’s population is nearly 
four times that of the United States, with 
nearly one third of Indian urban residents 
living in informal housing settlements, where 
unregulated cottage industries can prolifer-
ate without zoning or emissions controls 
(UN-HABITAT 2007).
Pollutants at toxic waste sites in LMICs 
can potentially have profound health effects. 
Lead and cadmium adversely affect neuro-
development in children, with the in utero 
period being the life stage of greatest vulner-
ability (Ciesielski et al. 2012; Hu et al. 2006). 
Children and women of childbearing age con-
stitute 65.3% of the total exposed popula-
tion in this analysis, highlighting the potential 
impact on these vulnerable populations. The 
majority of the chemicals are nephro toxic 
or hepatotoxic, and kidney and liver toxic-
ity accounted for the majority of noncancer 
health effects. Several are known carcinogens, 
including asbestos, cadmium, and chromium.
Previous work has described the difficulty 
in identifying which toxic chemicals are being 
generated in India via industrial processes, 
as well as which ones are being imported 
for recycling or disposal (Dutta et al. 2006). 
Table 3. YLDs, YLLs, and DALYs by chemical.
Chemical
No. of 
sites
Estimated 
population at risk YLDs YLLs DALYs
Aldrin 5 133,000 212 812 1,024
Asbestos 3 25,000 974 4,218 5,192
Cadmium 53 976,600 15 (S = 1, W = 14) 0 15
Chromium VI 128 3,231,750 63,174 (S = 3,582, 
W = 59,592)
235,483 (S = 14,467, 
W = 221,016)
298,657
DDT 4 180,000 4 18 22
Lead 79 1,829,900 523,630 0 523,630
Lindane 9 131,300 20 (S = 2, W = 18) 79 (S = 6, W = 73) 99
Mercury, inorganic 92 2,122,200 83 (S = 32, W = 51) 0 83
Total 373 8,629,750 588,112 240,610 828,722
Abbreviations: DDT, dichlorodiphenyltrichloroethane; S, soil; W, water.
Table 4. Sensitivity analysis estimates.
Scenario Total DALYs
Primary estimate of screened sites 828,722 DALYs(3,1)
Estimate without age weights 814,934 DALYs(3,0)
Estimate without age weights or discount rate 1,557,121 DALYs(0,0)
Remediation scenario 30,317 DALYs(3,1)
If actual exposed population is 25% less 621,541 DALYs(3,1)
If actual exposed population is 25% greater 1,035,902 DALYs(3,1)
If additional DW for lead-induced IQ loss not resulting in MMR is removed 483,201 DALYs(3,1)
If incidence is capped at 2.5% 730,627 DALYs(3,1)
If incidence is capped at 7.5% 922,479 DALYs(3,1)
Estimate of unscreened sites 3,500,000 DALYs(3,1)
Estimate of screened and unscreened sites 4,328,722 DALYs(3,1)
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The actual amount being produced and 
imported, and the ultimate fate of many of 
these chemicals, is unclear. Misra and Pandey 
(2005) discussed the complex requirements 
for proper handling of toxic waste to prevent 
human exposures and highlight the barriers 
to achieving this goal in countries such as 
India. Waste is often handled without ade-
quate control mechanisms, such as proper 
infrastructure and personal protective equip-
ment, in dense, highly populated areas, expos-
ing not only workers but also residents in the 
surrounding communities.
Our estimates highlight the need for reme-
diation of these sites, with a focus on addressing 
the key pollutant and dominant environmen-
tal medium. High-dose, mass poisonings 
periodically come to worldwide attention, 
such as recent events in Nigeria and Senegal, 
prompting immediate focus and remediation 
(Dooyema et al. 2012; Haefliger et al. 2009). 
However, exposures from most toxic waste sites 
continue unabated. Research has documented 
that waste site remediation can be cost-effective 
while reducing toxic exposures (Guerriero et al. 
2011; Jones et al. 2011).
We must note several limitations of this 
analysis. We examined only eight chemicals 
and restricted the analysis to only one chemi-
cal per site. Persons living near toxic waste 
sites are often exposed to multiple chemi-
cals simultaneously (DeRosa et al. 1996; 
Hu et al. 2007; Vrijheid 2000). Therefore, 
health effects may be increased or decreased 
due to the existence of co exposures and 
the potential for synergistic or antagon istic 
effects. For example, Claus Henn et al. (2011) 
documented a synergistic effect between lead 
and manganese in a Mexico City pregnancy 
cohort, with the impact of lead on child 
neuro development increasing in the group 
with higher levels of manganese.
For most of the chemicals, we assigned 
only one cancer and one noncancer health 
effect. In addition, only a limited number of 
diseases have an associated DW, which pre-
vented the inclusion of some health effects. 
For example, exposure to hexavalent chro-
mium can cause nasal perforation. However, 
there is no DW for nasal perforation, so this 
health effect was not included in the analysis. 
In several cases there were no specific DWs 
that aligned properly with the projected health 
effect. Because there is no DW for liver tox-
icity, for example, we applied the DW for 
advanced hepatic disease to those chemicals 
known to cause liver toxicity. Although the 
major health effect of mercury is the impact 
of in utero methyl mercury exposure on neuro-
development, we were unable to capture 
this health effect for various reasons (e.g., 
limited methyl mercury samples, no methyl-
mercury biomonitoring). An additional source 
of uncertainty is the calculation of YLD 
for cancer, in which each cancer stage was 
assigned a different duration and DW.
Limited environmental sampling occurred 
at most sites, forcing us to extrapolate results of 
several samples to the entire population at risk. 
Biomarkers of exposure were not obtained, so 
we were unable to confirm completed pathways 
of exposure. In the case of lead, we attempted 
to offset this limitation by utilizing the U.S. 
EPA’s IEUBK model and ALM, which predict 
BLLs expected as a consequence of environ-
mental lead exposure. However, these models 
may over estimate BLLs when predicted BLLs 
are > 30 µg/dL given the uncertainty in the 
relationship between environmental lead levels 
and BLLs at this level (Hogan et al. 1998). It 
is also likely that the actual exposures to the 
pollutants vary, with some individuals being 
exposed to lower levels. Despite evidence of 
prenatal exposure to environmental toxicants 
causing adverse health effects (Wigle et al. 
2008), our analysis did not account for effects 
of prenatal exposures other than lead.
In addition, we assumed that exposures 
continued for a lifetime because there are no 
established waste site remediation programs in 
most LMICs. Although complete elimination 
of the toxic exposure may not be feasible for 
each site, a reduction in high-level exposure 
would decrease our disease burden estimates. 
Remediation of all sites such that pollutant 
concentrations are below international stan-
dards could save 798,405 DALYs(3,1). Finally, 
a key limitation of this analysis is its reliance 
on slope factors, reference doses, and reference 
concentrations, largely based on animal test-
ing. These regulatory values may over estimate 
the disease burden given the limitations of 
animal testing and the assumptions required 
to extrapolate toxicity data from animals to 
humans (e.g., applying uncertainty factors). 
Acknowledging these limitations, we believe 
our analysis presents the best possible estimate 
of the burden of disease from these sites given 
current data.
Further research should better define the 
specific exposures occurring at toxic waste 
sites in LMICs by linking environmental 
sampling levels, biomarkers of disease, and 
health outcomes and focusing on uniquely 
vulnerable populations such as women who 
are pregnant, children, and the elderly. Such 
enhanced surveillance data will help provide 
context when comparing toxic waste sites 
with more recognized public health threats. 
This research should not preclude the imme-
diate remediation of existing sites given the 
disease and resulting costs to society that 
result from such exposures. Given that the 
majority of the DALYs estimated for the eight 
chemicals evaluated were due to lead and 
chromium exposures, remediation could be 
facilitated by selectively targeting lead- and 
chromium-contaminated sites.
Conclusions
This study documents that chemical pollut-
ants from toxic waste sites are a large and 
heretofore insufficiently studied public health 
problem in the three low- and middle-income 
Asian countries that we examined (India, 
Indonesia, and the Philippines). Disease and 
death caused by toxic chemicals contribute to 
the total burden of disease in these countries. 
We estimate that > 8 million persons in these 
countries suffered disease, disability, or death 
from exposures to industrial contaminants in 
2010, resulting in 828,722 DALYs(3,1). These 
findings underscore the urgent need for toxic 
waste sites around the world to be character-
ized and remediated and for the health of 
affected populations to be monitored.
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